ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135073 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135073; 2) Community: the network communities that were significantly associated with the response to NSC 135073; 3) Molecule: the relationships between components within communities and NSC 135073; 4) MDR: the compounds that were significantly associated with the NSC 135073.

NSC Compound Enrichment Correlation
NSC 747174 Null 0.024108502230778 0.4700604
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.024108502230778 0.65689606
NSC 753190 3,5-dichloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide 0.024108502230778 0.22904395
NSC 89822 Null 0.024108502230778 0.448037
NSC 683556 Camptothecin Derivative 0.0247979034812107 0.1552803
NSC 737698 Null 0.0247979034812107 0.27026742
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.024797903481211 0.71835478
NSC 331935 CHALCONE ANALOG 0.024797903481211 0.59045521
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.024797903481211 0.58153208
NSC 629595 Null 0.024797903481211 0.73001866
Total:99  Current:59    [First] [Prev] [Next] [Last]